The growing evidence in support of dental implant safety and efficacy continues to mount.
As reported on Medical News Today, ? The first study was a randomized controlled clinical trial (RCT) at 11 clinical centers in Europe, USA and Australia.? This study yielded a 98.1% 3-year survival rate for implants, and a ?mean decreases of less than 0.7 mm and 0.6 mm in the submerged and transmucosal groups respectively.?
The article continues, ?While RCTs demonstrate that products or treatments work well, they are usually conducted by specialists in selected and strictly controlled populations. This study was performed by dental practices and University clinics that are highly specialized in dental implantology, which raises the question of whether its excellent results can be reproduced in daily dental practice. To answer this, a large study using the same implant was conducted in Europe and the US, in which the dentists had to follow the product guidelines but were able to use the implant as they would in normal daily practice. The strength of this type of investigation, which is known as 'non-interventional study' (NIS), is that it documents real-life situations, in which indications, patients and conditions all vary widely.?
This second study included a total of 908 implants in 538 patients, with a 1-year survival rate of 98.5%.
The latest clinical trials conducted using Straumann Bone Level Implants seem like they will bolster the level of confidence that clinicians can have in providing implants for patients.